Cellworks | Personalized Cancer Therapy

Personalized Oncology Through
Multi-omic Therapy Biosimulation

Know an individual patient's response to therapies prior to treatment

WATCH VIDEO

Cellworks presents results of the myCare-203A trial at the IASLC World Conference on Lung Cancer
August 6 - 9, 2022
Read Announcements and More

Precise

PHYSICIAN

Extend lives with cancer treatment predictors

Read More

Personalized cancer treatments for your patients

PATIENT

Precise treatment today for a better tomorrow

Read More

PAYOR

Effective intervention for better patient outcomes; prolongs lives and saves costs

Read More

Insured support for cancer treatment

BIOPHARMA

Extend lives with cancer treatment predictors

Read More

Drug development through software cell modeling

Precision by Biosimulation

BIOSIMULATION
PLATFORM

PRECISION MEDICINE PRODUCTS

FEATURED CONTENT

FEATURED ARTICLE

Cellworks Singula™ TRI predicts clinical outcomes for esophageal adenocarcinoma: myCare-004

FEATURED PUBLICATION

Results of the myCare-004 esophageal adenocarcinoma study presented at ASCO 2022

FEATURED VIDEO

View how personalized therapy biosimulation works

FEATURED BLOG

Moving Oncology Beyond ‘One Mutation, One Drug’

NEWS

ASCO 2022 : Cellworks Singula™ TRI Provides Personalized OS and PFS Predictions…

myCare-024-04 Study Finds Cellworks Personalized Biosimulation Provides Superior OS and PFS Predi…

ASCO 2022 : Cellworks Singula™ TRI Predicts Personalized Treatment Outcomes for…

myCare-004 Study Finds Cellworks Personalized Therapy Biosimulation Provides Superior OS, DFS and…

COLLABORATORS

OUR PARTNERS IN REVOLUTIONIZING CANCER TREATMENT.

Top